thromboxanes has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlbrecht, S; Benkhoff, M; Dannenberg, L; Helten, C; Huhn-Wientgen, R; Kelm, M; Levkau, B; M'Pembele, R; Mourikis, P; Petzold, T; Polzin, A; Richter, H; Thienel, M; Zako, S; Zikeli, D | 1 |
| Wadman, M | 1 |
| Hashimoto, M; Matsukura, H; Sakai, K; Takeda, H; Tanabe, T | 1 |
| Eikelboom, JW; McQuillan, A | 1 |
4 other study(ies) available for thromboxanes and Cardiac Diseases
| Article | Year |
|---|---|
Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?
Topics: Aspirin; Chronic Disease; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation; Platelet Function Tests; Rivaroxaban; Thromboxanes | 2021 |
How does a painkiller harm the heart?
Topics: Analgesics; Animals; Drug Industry; Epoprostenol; Heart Diseases; Humans; Lactones; Mice; Randomized Controlled Trials as Topic; Sulfones; Thromboxanes | 2006 |
[Alternations in coagulation and fibrinolysis associated with extracorporeal circulation--the role of vasoactive prostanoids].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Cardiopulmonary Bypass; Child; Epoprostenol; Female; Fibrinolysis; Heart Diseases; Humans; Male; Middle Aged; Thromboxane B2; Thromboxanes | 1984 |
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Heart Diseases; Humans; Ibuprofen; Platelet Aggregation Inhibitors; Thromboxanes | 2002 |